Bingham University Gets NUC Approval To Offer Doctor Of Pharmacy Programme
Bingham University has received approval from the National Universities Commission (NUC) to launch its Doctor of Pharmacy (Pharm D) program starting from the 2024/2025 academic session.
The accreditation was granted following a rigorous resource verification exercise conducted by an expert panel from the NUC in late 2023. This process assessed the university’s infrastructure, faculty strength, and readiness to deliver a top-tier pharmacy education.
The NUC conveyed its approval through a letter addressed to the Vice-Chancellor. The document, signed by Abubakar M. Girei, the Acting Director of Academic Planning, confirmed the university’s eligibility to run the Pharm D program.
Expressing gratitude for the accreditation, the Vice-Chancellor acknowledged the NUC’s recognition of Bingham University’s commitment to academic excellence.
He extended his congratulations to the university community and urged faculty members to maintain their dedication to fostering high-quality education and research in the pharmacy field.
This milestone marks a major expansion in Bingham University’s academic offerings, reinforcing its position as a leading institution in pharmaceutical education.
ALSO READ: Bingham University Releases Part-Time Degree Admission Form 2024/2025
Find this useful? Please share!
